Centrus combines strong top‑line growth with a dramatically improved balance sheet and a clear strategic role in a critical segment of the nuclear fuel market. It holds a unique U.S. license and capability to produce HALEU, enjoys deep relationships with the Department of Energy, and maintains consistently positive free cash flow. High liquidity and net cash provide a cushion to support expansion, and disciplined overhead control helps keep the cost structure lean.

The company’s earnings and cash flows are volatile, margins have compressed over time, and results remain sensitive to contract timing and cost dynamics. A rapid increase in debt and capital spending raises execution risk: projects must deliver the expected returns to justify the larger balance sheet. The business is heavily exposed to regulatory, geopolitical, and policy shifts around nuclear energy, and to the uncertain pace of advanced reactor deployment. Limited visible R&D spending also raises the question of how innovation will be sustained over the very long term.

The forward picture for Centrus is closely tied to the trajectory of global nuclear energy and, in particular, the adoption of advanced reactors that require HALEU. If demand materializes in line with current expectations, the company is well positioned to benefit from its early lead and reinforced financial base. At the same time, investors should treat the path as inherently uncertain: timelines, policy decisions, and technology adoption can all shift, meaning outcomes could range from steady, high‑value growth to a more gradual build‑out that tests the durability of current investments and strategy.